MENG Qianying, HUANG Shan, NIE Rong, SU Bili, SHEN Yang. Case study of pharmaceutical care provided by clinical pharmacists for the department of neurology[J]. Journal of Pharmaceutical Practice and Service, 2021, 39(5): 460-464. doi: 10.12206/j.issn.1006-0111.202101037
Citation:
|
MENG Qianying, HUANG Shan, NIE Rong, SU Bili, SHEN Yang. Case study of pharmaceutical care provided by clinical pharmacists for the department of neurology[J]. Journal of Pharmaceutical Practice and Service, 2021, 39(5): 460-464. doi: 10.12206/j.issn.1006-0111.202101037
|
Case study of pharmaceutical care provided by clinical pharmacists for the department of neurology
- 1.
Department of Pharmacy, The Cangshan District of No. 900 Hospital of Joint Logistics Support Force of the PLA, Fuzhou 350002, China
- 2.
Department of Clinical Pharmacy, No. 900 Hospital of Joint Logistics Support Force of the PLA, Fuzhou 350025, China
- Received Date: 2021-01-15
- Rev Recd Date:
2021-06-23
Available Online:
2021-09-28
- Publish Date:
2021-09-25
-
Abstract
Objective To provide reference for clinical pharmacists to participate in rational drug use through case study. Methods Clinical pharmacists participated in the optimization of treatment plan and performed pharmaceutical care for the patients according to their own characteristics, drug interactions, compatibility contraindications and adverse drug reactions. Results Clinical pharmacists provided pharmaceutical care for the patients with cerebrovascular diseases, Parkinson's disease, encephalitis and other diseases in the Department of Neurology by using pharmaceutical expertise, retrieved evidence-based support from literature and participating in the formulation of treatment plans. Those achieved individualized drug treatment, improve patient compliance, reduced the occurrence of unreasonable usage and dosage, inappropriate drug combination and improper drug selection, the treatment of adverse drug reactions, drug safety, and rational drug use. Conclusion Clinical pharmacists need to use their sound professional ability and good communication skills to help doctors make individualized drug delivery plans to ensure the safety, effectiveness and economy of drug treatment.
-
References
[1]
|
卫生部. 关于加强医疗机构药事管理促进合理用药的意见(国卫医发〔2020〕2号)[S]. 2020. |
[2]
|
任丽, 吴伟, 赵伟, 等. 阿加曲班治疗进展性脑梗死的有效性与安全性[J]. 中华神经科杂志, 2013, 46(8):551-554. doi: 10.3760/cma.j.issn.1006-7876.2013.08.014 |
[3]
|
周肖龙, 张宁, 王春检, 等. 氯吡格雷联合阿加曲班治疗大动脉粥样硬化性脑梗死疗效及安全性的Meta分析[J]. 滨州医学院学报, 2020, 43(3):182-185, 208. |
[4]
|
张祁, 李春梅, 张丽伟, 等. 阿加曲班对比阿加曲班联合氯吡格雷治疗急性脑梗死的效果[J]. 血栓与止血学, 2016, 22(3):258-259, 263. doi: 10.3969/j.issn.1009-6213.2016.03.005 |
[5]
|
萧云, 谭泽梁. 阿加曲班治疗进展性脑梗死疗效观察[J]. 按摩与康复医学, 2015, 6(19):81-83. |
[6]
|
PERFECT J R, DISMUKES W E, DROMER F, et al. Clinical practiceguidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America[J]. Clin Infect Dis,2010,50(3):291-322. doi: 10.1086/649858 |
[7]
|
中华医学会感染病学分会. 隐球菌性脑膜炎诊治专家共识[J]. 中华传染病杂志, 2018, 36(4):193-199. doi: 10.3760/cma.j.issn.1000-6680.2018.04.001 |
[8]
|
中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南(2010)[J]. 中国临床医生, 2011, 39(11):68-74. |
[9]
|
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 肝脏, 2015, 20(10):750-767. doi: 10.3969/j.issn.1008-1704.2015.10.002 |
[10]
|
中华医学会, 中华医学会消化病学分会. 药物性肝损伤基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19(10):868-875. doi: 10.3760/cma.j.cn114798-20200812-00900 |
[11]
|
王陶陶, 董宇, 常生, 等. 朱砂毒性的研究进展[J]. 沈阳药科大学学报, 2018, 35(10):897-902. |
[12]
|
WANG H F, SU G Y, CHEN G, et al. 1H NMR-based metabonomics of the protective effect of Curcuma longa and curcumin on cinnabar-induced hepatotoxicity and nephrotoxicity in rats[J]. J Funct Foods,2015,17:459-467. doi: 10.1016/j.jff.2015.04.014 |
-
-
Proportional views
-